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One Sentence Summary: A GWAS meta-analysis of almost 300,000 individuals identifies 
74 independent SNPs associated with educational attainment, pointing to genes, pathways, 
and tissue types known to be involved in brain development and structure, and the 
architecture of axon-dendrite connections.  
Summary: Educational attainment has important consequences for a range of economic, 
social, and health outcomes. Although it is known to be substantially heritable in developed 
countries, few specific variants have been credibly identified. Here we report a large genome-
wide association study of 293,723 individuals. We identify 74 independent genome-wide-
significant SNPs. Genetic associations are enriched for genes, pathways, and tissue types 
known to be involved in brain development and the architecture of axon-dendrite connections. 
The genes in our identified loci are preferentially expressed in neural tissue, particularly during 
prenatal development, and are implicated in brain size and structure. The genetic loci 
disproportionately reside in genomic regions regulating gene expression in the fetal brain. A 
genome-wide pattern of education-increasing variants is associated with increased cognitive 
performance, intracranial volume, and height, an increased risk of schizophrenia and bipolar 
disorder, decreased risk of Alzheimer’s, and lower neuroticism. 
Main Text: 
Educational attainment (EA) has important consequences for a range of economic, social, and 
health outcomes1,2. Discovery of genetic variants associated with EA may yield insights into 
the biological pathways underlying phenotypes3, such as neuropsychiatric conditions4 and 
brain morphology, that may exhibit genetic overlap with EA. In addition, a “polygenic score” 
for EA—an index that aggregates the effects of many genetic variants—can be useful in 
empirical research as a control for unobserved heterogeneity, or to study gene-environment 
interactions5. 
Across developed countries, genetic factors as a whole account for a modest to moderate share 
of the variation across individuals, roughly 40% on average6. Yet as with other behavioral 
traits, few credible genetic associations have been identified. The largest genome-wide 
association study (GWAS) meta-analysis of EA to date had a discovery sample of N = 101,069 
and identified 3 genome-wide significant single nucleotide polymorphisms (SNPs)7. Here, we 
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report the results of a GWAS meta-analysis in a sample of N = 293,723, which brings the 
number of SNPs to 74. Our sample size enables us to obtain informative results from many 
additional analyses, such as providing evidence for a number of key biological pathways and 
quantifying genetic overlap with neuropsychiatric disorders and other phenotypes. 
 
Identification of 74 Lead SNPs 
 
We examined two phenotypes: a variable measuring the number of years of schooling 
completed (EduYears, N = 293,723, mean = 14.33, SD = 3.61) and an indicator variable for 
college completion (College, N = 280,007, mean = 0.29). We harmonized the study-specific 
measures of EA using the International Standard Classification of Education (ISCED 1997) 
scale. All analyses were performed at the cohort level using the 1000 Genomes Project 
reference panel8 according to a public analysis plan. The estimation sample is restricted to 
individuals of European descent whose EA was assessed at age 30 or older. A uniform set of 
quality-control (QC) procedures were used, including but not limited to the best practices 
previously recommended9. EduYears was our primary outcome variable and was used for all 
follow-up analyses (such as biological annotation). The analyses are based on ≈9.3M SNPs 
that passed QC filters. We applied single genomic control at the cohort level and meta-analyzed 
results using sample-size weighting. 
 
To define the number of approximately independent genome-wide-significant signals—
henceforth “lead SNPs”—we first clumped the genome-wide-significant signals in PLINK10 
using an r2 threshold of 0.1 and a distance threshold of 500 kb. We then further pruned the 
resulting set of index SNPs by checking for long range LD (r2 > 0.5) between each pair on the 
same chromosome. The Manhattan plot for EduYears is shown in Fig. 1. The 74 lead SNPs, 
each representing a locus (which include the 3 previously identified SNPs7), are highlighted. 
Extended Data Fig. 1 provides Manhattan plots for the sex-stratified analyses of EduYears and 
the pooled College analysis. As in the earlier GWAS of EA7 and other large GWAS of 
polygenic traits11–13, the Q-Q plot of the meta-analysis (Extended Data Fig. 2) exhibits inflation 
(λGC = 1.28), consistent with a polygenic architecture. Extended Data Fig. 3 shows the 
distribution of the estimated effect sizes on EduYears of the lead SNPs. They are in the range 
0.05 to 0.17 years of schooling (approximately 3 to 9 weeks) per allele, with R2 in the range 
0.01% to 0.035%. 
 
Given the very small R2’s, an important concern is that results could be driven by very subtle 
population stratification that remains even after the stringent controls used by the cohorts (see 
Supplementary Information section 1.4)14. As a standard first test, we calculated how often the 
signs of the regression coefficients aligned across two independent meta-analyses: a within-
family analysis conducted in dizygotic (DZ) twin pairs from four cohorts (STR, MCTFR, NTR, 
and QIMR; N = 8,233 DZ twin pairs in total), and the GWAS meta-analysis excluding these 
cohorts. Of the 66 lead SNPs available in all four cohorts, the signs aligned 62% of the time, 
significantly more than the 50% expected under the null that the results are entirely due to 
stratification (P = 0.032). Additionally, we quantified the amount of stratification in the GWAS 
estimates using LD Score regression15. The results indicate that 8% of the observed inflation 
in the mean 𝜒2 is accounted for by bias rather than polygenic signal (Extended Data Fig. 4a), 
suggesting that stratification is not a major concern in the analyses that follow. 
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Genetic Overlap with Other Phenotypes 
 
We used bivariate LD Score regressions15 to estimate the genetic correlation between EduYears 
and each of 14 phenotypes for which we obtained published GWAS results: 3 neuropsychiatric 
conditions (bipolar disorder, schizophrenia, Alzheimer’s), 2 anthropometric traits (BMI, 
height), 2 behavioral traits (neuroticism, cognitive performance), intracranial volume (ICV), 
and volumes of 6 subcortical brain structures adjusted for ICV. As shown in Fig. 2a (and 
Supplementary Table 3.1), the genetic correlations are statistically distinguishable from zero 
for all the non-subcortical-structure phenotypes. Overall, having more EA-increasing alleles is 
associated with increased cognitive performance, intracranial volume, and height, an increased 
risk of schizophrenia and bipolar disorder, and a decreased Alzheimer’s risk and lower 
neuroticism. Bulik-Sullivan et al.4 used the earlier EA GWAS7 results to study some of the 
same phenotypes. For the overlapping phenotypes, our estimates are similar to theirs. However, 
we observe the largest genetic correlations for three phenotypes not studied by Bulik-Sullivan 
et al.: cognitive performance (?̂?𝐺  = 0.75), neuroticism (−0.41), and intracranial volume (0.34). 
 
Next, we looked up our lead SNPs in the phenotypes’ GWAS results (Fig. 2b and Extended 
Data Fig. 5). When we test the 74 SNPs jointly for association, we reject the null hypothesis of 
no enrichment at p < .05 for 10 of the 14 phenotypes (all the exceptions are subcortical brain 
structures). We typically find stronger enrichment for phenotypes whose estimated genetic 
correlation is further from zero. An intriguing exception is schizophrenia: it is very strongly 
enriched for our lead SNPs, but its genetic correlation is close to zero because the SNPs have 
opposing affects on the phenotype: roughly half with concordant effects on EduYears and half 
discordant. In these lookup exercises, enrichment could arise for several reasons, including (i) 
pleiotropy, (ii) co-localization of distinct causal genes (e.g., the genes associated with 
education might be near the genes associated with schizophrenia), or (iii) the phenotype 
mediates genetic effects on EduYears (this last being most plausible for cognitive performance 
and neuroticism). 
 
We examined whether individual SNPs’ P-values reached a significance threshold of 0.05/74 
across the 14 phenotypes. We observed a total of 25 significant associations (Supplementary 
Table 3.4). Several of these replicate previously known associations with BMI11, cognitive 
performance16, height13, intracranial volume17,18, and schizophrenia12. Others are not within 
1,000 kB of any genome-wide significant SNPs reported in previous GWAS; for example, we 
observe one such association each with Alzheimer’s, cognitive performance, neuroticism, 
schizophrenia, hippocampal volume, and intracranial volume (Extended Data Fig. 6, 
Supplementary Table 3.3). 
 
Biological Annotation 
 
To identify candidate biological pathways and genes, we probed the loci identified in our 
analyses with a number of bioinformatic tools. 
 
Using an empirical Bayesian hierarchical model applied to all SNPs regardless of statistical 
significance19, we estimated that DNase I hypersensitive regions (i.e., regions related to gene 
expression) in the fetal brain are enriched for EduYears-associated SNPs by a factor of ≈5 
(Extended Data Fig. 7a,b). As a robustness check, we reapplied our method using an alternative 
set of annotations from the Roadmap Epigenomics data and found quantitatively similar results 
(Supplementary Table 4.2.3). We also found that EduYears-associated SNPs are enriched 
positively in regions that are evolutionarily conserved in mammals and negatively in regions 
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that are transcriptionally repressed (Extended Data Fig. 7a and Supplementary Table 4.4.1), 
results that accord with a trend observed in the analysis of other phenotypes19,20.  
 
Our two tissue-level analyses also implicate brain-specific gene regulation. First, we used LD 
Score regression to estimate an enrichment factor—the fraction of the EduYears genetic 
variance explained by SNPs residing in regions associated with histones marked specifically 
in a particular type of tissue, divided by the fraction of SNPs bearing this tissue-specific 
annotation—for each of 10 tissue types (Supplementary Table 4.4.2)20. We also applied the 
same procedure to three phenotypes—height13, body mass index (BMI)11, and waist-to-hip 
ratio adjusted for BMI (WHR)21—that have been studied using samples sizes comparable to 
ours. A striking pattern in Extended Data Fig. 8 is that each of the 10 tissue types in this 
analysis, with one exception, is more enriched by WHR and height than by EduYears and BMI. 
The exception is the central nervous system, which is most enriched by EduYears (~3-fold). 
This finding is consistent with Finucane et al.20, which contains an application of the same 
method to the earlier EA GWAS7 results. Second, turning to direct measurements of gene 
expression, we tested the 37 adult tissues from the Genotype-Tissue Expression Project22 for 
enrichment by mRNA transcribed from genes within loci defined by the enrichment-analysis 
tool DEPICT23. The 13 tissues that are components of the central nervous system are the only 
ones that are significantly enriched (Extended Data Fig. 9a and Supplementary Table 4.5.2). 
 
We examined the functions of genes that overlap DEPICT-defined loci, centering on SNPs 
attaining P < 1×10−5 (Supplementary Tables 4.1.5 and 4.5.1). We used the same tool to 
nominate candidate functional genes within our loci. DEPICT identified 283 sets of 
functionally related genes (FDR < 0.05) (Supplementary Table 4.5.1). To help interpret the 
results, we partitioned the gene sets into 34 clusters (shown in Fig. 3a) based on degree of gene 
overlap. The gene sets map onto many processes of neural development: the proliferation of 
neural progenitor cells and their specialization (npBAF complex), the migration of new neurons 
to the different layers of the cortex (forebrain development, abnormal cerebral cortex 
morphology), the projection of axons from neurons to their signaling targets (axonogenesis, 
signaling by Robo receptor), the sprouting of dendrites and their spines (dendrite, dendritic 
spine organization), and neuronal signaling and synaptic plasticity throughout the lifespan 
(voltage-gated calcium channels, synapse part, synapse organization). In light of the moderate 
genetic correlation between EduYears and intracranial volume (Fig. 2a), we note that the cluster 
named after abnormal cerebral cortex morphology contains sets of genes that lead to 
pathological phenotypes such as decreased brain size and irregular layering of the cerebral 
cortex when knocked out or otherwise perturbed in mice24. 
 
Signaling by EGFR is named after a pathway where mutations contribute to overproduction of 
glial cells25, and one of its members emerged as the top gene set in a recent GWAS of 
intracranial volume18. Most of the clusters above and to the left of signaling by EGFR in Fig. 
3a are clearly neural in nature; some of the clusters below and to the right are less obviously 
so. These latter clusters (protein kinase binding, transcription cofactor activity, histone 
acetyltransferase complex) may appear to represent routine housekeeping pathways of little 
specific relevance to cognition, but in fact recent studies point to the importance of 
transcriptional regulation and chromatin remodeling in polygenic neuropsychiatric disorders26. 
Indeed, many of our DEPICT-nominated genes that are involved in determining the size and 
structure of the cortex encode transcription factors and components of nucleosome remodelers 
(Supplementary Table 4.5.1). 
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As candidates for follow-up work, Table 1 and Supplementary Table 4.1 list a number of 
individual genes implicated by convergent lines of evidence from ten analyses (the table 
captions describe how the genes were selected). Two of the most strongly prioritized genes 
(FOXO6, FOXP2) encode proteins belonging to the forkhead family of transcription factors. 
FOXP2 was the first gene to be implicated in language, and it has undergone two 
nonsynonymous substitutions since the divergence of the human lineage from other primates27. 
Several genes, including MAPT28 and HTT29, can mutate to cause neurodegenerative disorders. 
(Notably, our evidence does not implicate APOE/TOMM40, a gene linked to cognitive decline 
and Alzheimer’s disease30,31.) One of the first SNPs found to be associated with EduYears was 
rs93209137, and its nearest gene (POU3F2) was implicated in our subsequent study of 
cognitive performance16. This gene is the highest-ranking DEPICT-nominated member of 
several significantly enriched gene sets, including decreased brain size, central nervous system 
neuron differentiation, and abnormal axon guidance. Many of the genes are already known to 
be involved in axon genesis and guidance (DCC32, SEMA6D33, PCDH1734.) A particularly 
interesting gene in this respect is MAP4, which is normally regarded as a non-neuronal 
microtubule-associated protein but nevertheless emerges as one of our top candidates and a 
predicted participant in the pathways signaling by Robo receptor and axon guidance. 
 
Previous large-scale GWAS have observed a pattern: genes in which de novo mutations are 
known or believed to cause syndromic forms of a disease are enriched in GWAS-identified 
loci12,13. To test for this pattern in our results, we examined whether our 74 lead loci 
disproportionately overlap genes where de novo mutations can cause (a) intellectual disability 
(ID), a syndrome characterized by low levels of cognitive performance, (b) a large effect on 
liability to autism spectrum disorder (ASD), and (c) a large effect on liability to schizophrenia 
(SCZ). Fig. 3b shows that genes nominated by DEPICT related to EduYears exhibit substantial 
overlap with ID genes (OR = 4.61), more so than DEPICT-nominated genes for the three 
anthropometric traits. Conversely, genes nominated by DEPICT for height and WHR exhibit 
substantial overlap with genes where mutations can cause syndromic skeletal disorders, much 
more so than EduYears genes. We also found that our EduYears loci harbor significantly more 
ID and ASD genes than randomly chosen sets of loci selected to match the EduYears loci in 
certain genomic properties23. Extended Data Fig. 9b shows the DEPICT-nominated EduYears 
genes where mutations have been implicated in ID, ASD, and SCZ.  
 
Our results above implicate a critical role for brain-specific gene expression during prenatal 
development, but do not test for expression during prenatal versus other periods of life. We did 
so using the BrainScan Developmental Transcriptome35 data. We found that the DEPICT-
prioritized genes exhibit above-baseline expression in the brain throughout life but higher 
expression levels in the brain specifically during prenatal development (1.36-fold over 
postnatal, one-sided paired t-test P = 4.2×10−8; Fig. 3c). 
 
Polygenic prediction 
 
To assess the joint predictive power afforded by the GWAS results, we constructed polygenic 
scores for EduYears using sets of SNPs whose nominal P-values fall below a certain threshold, 
ranging from 5×10-8 (only the genome-wide significant SNPs were included) to 1 (all measured 
SNPs were included). For weights, we re-estimated the SNP effects jointly in a multiple-SNPs 
model using GCTA-COJO (Supplementary Table 5.1; the all-SNPs score uses the meta-
analysis weights). We constructed each version of the score twice, excluding either STR or 
HRS (N = 9,339 and 8,538 unrelated individuals, respectively), and tested the predictive power 
of the scores in the excluded cohort (Fig. 4a and Supplementary Table 5.2). As expected for a 
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highly polygenic trait, the fraction of variance explained increases as the P-value threshold 
becomes less conservative. The score that includes all SNPs predicts 2.6% of the variance in 
the STR sample and 3.8% in the HRS sample. The sample-sized-weighted mean is 3.2%. 
 
To assess the extent to which population structure in the replication samples might account for 
the explanatory power of the score, we used the method of Wood et al.13 on the DZ-twin data 
in STR (N = 3,515 pairs) to partition the variance of the score built with the SNPs meeting 
selected P-value thresholds into components due to real SNP effects from SNPs that are in LD, 
to real SNP effects from SNPs that are correlated due to population structure, and to estimation 
error (Supplementary Table 2.2). We find that the variance explained by real SNP effects is 
sizeable, both before and after residualizing the score on 10 PCs of the genotypic data (Fig. 
4b,c). As an additional test, we regressed EduYears on the all-SNPs score using only the within-
family variation in STR (Supplementary Table 2.2). The coefficient, 0.215 (s.e. = 0.081), is 
statistically distinguishable from zero (P = 0.008), further indicating that the score captures 
real SNP effects. 
 
While the explanatory power of the all-SNPs score seems smaller than expected (see 
Supplementary Information section 5.2), it is large enough to be useful for other studies. To 
illustrate, we study mediation of the effect of the all-SNPs score on EA in two of our cohorts. 
We find that cognitive performance can statistically account for 23-42% of the effect, and the 
personality trait “openness to experience” can statistically account for roughly 7% 
(Supplementary Tables 6.3 and 6.4, Supplementary Information section 6). We also used the 
all-SNPs score in STR (calculated excluding STR) to analyze how the strength of the 
association between the score and EduYears varies with birth cohort (Extended Data Fig. 10, 
Supplementary Information section 7). We find that the predictive power of the score for the 
oldest individuals in the sample (born in 1929) is almost twice as large as for the youngest 
(born in 1958) (P = 0.004). This finding suggests that the expansion of educational opportunity 
in Sweden, similar to that which occurred in many developed countries during the 20th century, 
may have altered the complex causal pathways from genes to education in a way that produced 
greater equality in EA. 
 
Discussion 
 
This study of EA is the largest GWAS of a behavioral phenotype reported to date. Our results 
reveal strong parallels between EA and anthropometric and medical phenotypes such as height 
and schizophrenia. As with these other phenotypes, the GWAS methodology has become far 
more productive as sample sizes have increased36: for EA, from 3 genome-wide significant 
SNPs for N ≈ 100,0007 to 74 SNPs for N ≈ 300,000. Large samples have enabled a range of 
statistically well-powered analyses, generating both confirmations of prior findings and many 
new discoveries. The advances we report here suggest that GWA studies of other behavioral 
phenotypes for which no credible associations have yet been established may have success as 
larger discovery samples become available. 
 
Our study also allows us to further refine our understanding of how EA compares quantitatively 
to anthropometric and medical phenotypes along several dimensions. For instance, Rietveld et 
al.7 found, as do we, that in terms of R2, the explanatory power of the top EduYears-associated 
SNPs (in the range 0.02% to 0.03%) is roughly one-tenth as large as that of the top height- and 
BMI-associated SNPs (in the range 0.3% to 0.4%). As we expand the number of identified 
SNPs to 74, we find that outside the top 3 SNPs, the ratio of variance explained falls to a factor 
of roughly 6 for height and 2 for BMI. 
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Moreover, our biological analyses yield a range of novel and distinctive results when applied 
to EA. In particular, we identify biological pathways that relate EA to brain development 
(especially prenatally), neuropsychiatric disorders, and the architecture of axon-dendrite 
connections. 
 
Our study begins to elucidate some of the complex pathways by which genetic variants 
influence EA. Such knowledge is valuable both for the identification of associations with more 
proximal phenotypes, for which large-sample GWAS are currently not feasible, and for 
enhancing our understanding of how environmental factors, including policies, interact with 
genetic effects. 
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Figure 1 | Manhattan plot for EduYears associations (N = 293,723). 
The x-axis is chromosomal position, and the y-axis is the significance on a –log10 scale. The black line shows the genome-wide significance level 
(5×10-8). The red x’s are the approximately 74 independent genome-wide significant associations (“lead SNPs”). The black dots labeled with rs 
numbers are the 3 Rietveld et al.7 SNPs. 
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Figure 2 | Genetic overlap between EduYears and other traits.  
a, Results from Linkage-Disequilibrium (LD) Score regressions: estimates of genetic 
correlation with brain volume, neuropsychiatric, behavioral, and anthropometric phenotypes 
for which GWAS summary statistics were available in the public domain. b, Q-Q plots for the 
74 lead EduYears SNPs in selected phenotypes (for other phenotypes, see Extended Data Fig. 
5). SNPs with concordant effects on both phenotypes are pink, and SNPs with discordant 
effects are blue. SNPs outside the gray area pass Bonferroni-corrected significance thresholds 
that correct for the total number of SNPs we tested (P < 0.05/74 = 6.8×10-4) and are labeled 
with their rs numbers. For the sign concordance test: * P < 0.05, ** P < 0.01, and *** P < 
0.001. 
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Figure 3 | Overview of biological annotation.  
a, We identified 283 significantly (FDR < 0.05) enriched reconstituted gene sets, which we 
grouped into the 34 clusters displayed in the graph using the Affinity Propagation method. 
Each cluster is named after one of its member gene sets. The color represents the P-value of 
the member set exhibiting the most statistically significant enrichment. Overlap between the 
named representatives of two clusters is represented by an edge. Edge width represents the 
Pearson correlation ρ between the two respective vectors of gene membership scores (ρ < 
0.3, no edge; 0.3 ≤ ρ < 0.5, thin edge; 0.5 ≤ ρ < 0.7, intermediate edge; ρ ≥ 0.7, thick edge). 
b, For each of the plotted disorders, we calculated the odds ratio corresponding to the overlap 
between genes where de novo mutations have been implicated in the disorder and genes 
nominated by DEPICT as affecting the given GWAS phenotype. The absence of a bar 
indicates no overlap. EduYears, years of education; BMI, body mass index; WHR, waist-to-
hip ratio adjusted for BMI. c, The genes in the intersection of DEPICT prioritization for 
EduYears and BrainSpan Developmental Transcriptome data (red curve) exhibit higher 
expression in the brain during prenatal relative to postnatal stages. The prioritized genes 
exhibit similar median gene-expression levels across different brain areas (gray lines). 
Analyses were based on median log2-transformed RNA-Seq data. Error bars represent 95% 
confidence intervals. 
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Figure 4 | Variance explained by EduYears-associated SNPs at different levels of significance. SNPs were selected from the GCTA-COJO 
analysis with the validation cohort excluded from the meta-analysis. a, Predictive power of the polygenic score in unrelated individuals. Cohorts 
are HRS (pink) and STR (green). The y-axis is the variance explained (incremental R2 from including the score in the regression). The line is the 
sample-size-weighted mean R2. The score is residualized on the first 10 principal components. b,c, Partitioning the variance of the SNP-derived 
polygenic score using a within-family analysis in STR. The polygenic score is not adjusted in b, and residualized on the first 10 principal 
components in c. The four variance and covariance components Vg, Ve, Cg and Ce are defined in Supplementary Information section 3.5. 
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Table 1 | Significantly prioritized EduYears-associated genes. For each gene we report any of three neuropsychiatric diseases reported to be 
caused by de novo mutations. We also report up to three of the most significantly enriched non-PPI reconstituted gene sets (other than the MP 
category decreased fear-related response). When there is more than one independent significant SNP in the DEPICT-defined locus, we give only 
the one with the lowest GWAS P-value. Not all SNPS in the top part of the table reached P < 5×10−8. ID, intellectual disability; ASD, autism 
spectrum disorder; SCZ, schizophrenia; MP, Mouse Phenome; PPI, InWeb protein-protein interaction subnetwork. 
GWAS 
locus 
Gene 
symbol 
Syndromic 
gene 
Prioritization 
P-value 
Lines of 
evidence 
Top-ranking reconstituted gene sets 
Top 10 genes by DEPICT prioritization (see Supplementary Table 4.1) 
rs34328009 CAMTA1 – 4.7×10−13 2 abnormal dorsal root ganglion morphology, G alpha (12/13) signaling events  
rs58852793 PPP6R2 – 5.2×10−12 3 
abnormal striatum morphology, histone deacetylase activity (H3K9 specific), NAD-dependent 
histone deacetylase activity 
rs35436312 FOXO6 – 1.2×10−11 3 dendrite development, regulation of cell development 
rs72771875 MEF2C ID, ASD 1.4×10−8 5 
ErbB signaling pathway, abnormal sternum ossificiation, regulation of muscle cell 
differentiation 
rs9544418 NBEA SCZ 1.8×10−8 4 developmental biology, signaling by Robo receptor, dendritic shaft 
rs12754946 USP33 – 6.1×10−8 3 protein serine/threonine phosphatase complex 
rs111730030 NACC1 – 6.8×10−8 2 transcription factor binding, kinase binding, regulation of cell development 
rs11191193 MGEA5 – 1.5×10−7 2 protein kinase binding, kinase binding 
rs12987662 LONRF2 – 4.4×10−7 3 ectopic cerebellar granule cells, dendritic spine organization, synapse organization 
rs11712056 IP6K2 – 6.0×10−7 2 transcription coactivator activity, SWI/SNF-type complex, nBAF complex 
Top 15 genes in the 74 EduYears loci (P < 5×10−8) by lines of evidence (see Supplementary Table 4.5.1) 
rs4500960 TBR1 ID, ASD 6.3×10−4 6 developmental biology, decreased brain size, abnormal cerebral cortex morphology 
rs61160187 ZSWIM6 – 1.3×10−4 5 
transcription factor binding, negative regulation of signal transduction, PI3K events in ErbB4 
signaling 
rs2457660 BCL11A ASD 7.6×10−4 5 
dendritic spine organization, abnormal hippocampal mossy fiber morphology, SWI/SNF-type 
complex 
rs11712056 CELSR3 SCZ 8.9×10−4 5 
dendrite morphogenesis, dendrite development, abnormal hippocampal mossy fiber 
morphology 
rs192818565 MAPT ID 9.5×10−4 5 
dendrite morphogenesis, abnormal hippocampal mossy fiber morphology, abnormal axon 
guidance 
rs7306755 SBNO1 SCZ 7.2×10−3 5 protein serine/threonine phosphatase complex 
rs12987662 NBAS – 0.05 5 – 
rs1871109 SMARCA2 ID 8.8×10−6 4 – 
rs11712056 MAP4 ASD 2.6×10−5 4 developmental biology, signaling by Robo receptor, SWI/SNF-type complex 
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rs10061788 LINC00461 – 6.8×10−5 4 
decreased brain size, abnormal cerebral cortex morphology, abnormal hippocampal mossy 
fiber morphology 
rs9320913 POU3F2 – 3.6×10−4 4 dendrite morphogenesis, developmental biology, decreased brain size 
rs11712056 RAD54L2 SCZ 4.8×10−4 4 decreased brain size, SWI/SNF-type complex, nBAF complex 
rs2964197 PLK2 – 8.1×10−4 4 negative regulation of signal transduction, PI3K events in ErbB4 signaling 
rs9537821 PCDH17 – 1.6×10−3 4 activation of RAC, abnormal axon guidance, axon guidance (Reactome) 
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